132 related articles for article (PubMed ID: 26423037)
1. Virtual Screening with Docking Simulations and Biochemical Evaluation of VHY Phosphatase Inhibitors.
Park H; Lee HS; Kim SJ
Chem Pharm Bull (Tokyo); 2015; 63(10):807-11. PubMed ID: 26423037
[TBL] [Abstract][Full Text] [Related]
2. Identification of potent VHZ phosphatase inhibitors with structure-based virtual screening.
Park H; Park SY; Oh JJ; Ryu SE
J Biomol Screen; 2013 Feb; 18(2):226-31. PubMed ID: 23042075
[TBL] [Abstract][Full Text] [Related]
3. Homology modeling and virtual screening approaches to identify potent inhibitors of slingshot phosphatase 1.
Park H; Park SY; Ryu SE
J Mol Graph Model; 2013 Feb; 39():65-70. PubMed ID: 23220283
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening.
Park H; Chien PN; Ryu SE
Bioorg Med Chem Lett; 2012 Oct; 22(20):6333-7. PubMed ID: 22989533
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel DUSP16 phosphatase inhibitors through virtual screening with homology modeled protein structure.
Park H; Park SY; Nam SW; Ryu SE
J Biomol Screen; 2014 Dec; 19(10):1383-90. PubMed ID: 25245988
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR).
Park H; Choe H; Hong S
Bioorg Med Chem Lett; 2014 Feb; 24(3):835-8. PubMed ID: 24393580
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations.
Park H; Yu KR; Ku B; Kim BY; Kim SJ
Theor Biol Med Model; 2013 Aug; 10():49. PubMed ID: 23981594
[TBL] [Abstract][Full Text] [Related]
8. Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors.
Park H; Choi H; Hong S; Kim D; Oh DS; Hong S
Bioorg Med Chem Lett; 2011 Apr; 21(7):2021-4. PubMed ID: 21354792
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors.
Park H; Kim SY; Kyung A; Yoon TS; Ryu SE; Jeong DG
Bioorg Med Chem Lett; 2012 Jan; 22(2):1271-5. PubMed ID: 22115589
[TBL] [Abstract][Full Text] [Related]
10. Structure-based virtual screening approach to the discovery of novel inhibitors of eyes absent 2 phosphatase with various metal chelating moieties.
Park H; Jung SK; Yu KR; Kim JH; Kim YS; Ko JH; Park BC; Kim SJ
Chem Biol Drug Des; 2011 Oct; 78(4):642-50. PubMed ID: 21777393
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based virtual screening and experimental validation of novel inhibitors against cyanobacterial fructose-1,6-/sedoheptulose-1,7-bisphosphatase.
Sun Y; Zhang R; Li D; Feng L; Wu D; Feng L; Huang P; Ren Y; Feng J; Xiao S; Wan J
J Chem Inf Model; 2014 Mar; 54(3):894-901. PubMed ID: 24524690
[TBL] [Abstract][Full Text] [Related]
12. Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver.
Hoeger B; Diether M; Ballester PJ; Köhn M
Eur J Med Chem; 2014 Dec; 88():89-100. PubMed ID: 25159123
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.
Zhou C; Kang D; Xu Y; Zhang L; Zha X
Chem Biol Drug Des; 2015 Jun; 85(6):659-71. PubMed ID: 25346381
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
[TBL] [Abstract][Full Text] [Related]
15. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of hydrolysis-resistant pyridoxal 5'-phosphate analogs and their biochemical and X-ray crystallographic characterization with the pyridoxal phosphatase chronophin.
Knobloch G; Jabari N; Stadlbauer S; Schindelin H; Köhn M; Gohla A
Bioorg Med Chem; 2015 Jun; 23(12):2819-27. PubMed ID: 25783190
[TBL] [Abstract][Full Text] [Related]
17. Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening.
Wu JS; Lin SY; Liao FY; Hsiao WC; Lee LC; Peng YH; Hsieh CL; Wu MH; Song JS; Yueh A; Chen CH; Yeh SH; Liu CY; Lin SY; Yeh TK; Hsu JT; Shih C; Ueng SH; Hung MS; Wu SY
J Med Chem; 2015 Oct; 58(19):7807-19. PubMed ID: 26348881
[TBL] [Abstract][Full Text] [Related]
18. Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.
Rudling A; Gustafsson R; Almlöf I; Homan E; Scobie M; Warpman Berglund U; Helleday T; Stenmark P; Carlsson J
J Med Chem; 2017 Oct; 60(19):8160-8169. PubMed ID: 28929756
[TBL] [Abstract][Full Text] [Related]
19. Structure-based de novo design of Eya2 phosphatase inhibitors.
Park H; Ryu SE; Kim SJ
J Mol Graph Model; 2012 Sep; 38():382-8. PubMed ID: 23085179
[TBL] [Abstract][Full Text] [Related]
20. Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors.
Choi H; Park HJ; Shin JC; Ko HS; Lee JK; Lee S; Park H; Hong S
Bioorg Med Chem Lett; 2012 Mar; 22(6):2195-9. PubMed ID: 22342625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]